首页> 外文期刊>Clinical Case Reports >Colchicine reduced pericardial effusion due to postcardiac injury syndrome following cardiac resynchronization therapy implantation
【24h】

Colchicine reduced pericardial effusion due to postcardiac injury syndrome following cardiac resynchronization therapy implantation

机译:心脏再同步治疗植入后秋水仙碱减少了因明信片损伤综合征引起的心包积液

获取原文
           

摘要

Key Clinical Message We present a case of postcardiac injury syndrome with pericardial effusion following cardiac resynchronization therapy implantation which was treated by only colchicine. Although treatment using colchicine is not as common as NSAIDs or steroids, colchicine seems to be an effective and safe treatment option for the syndrome.
机译:关键临床信息我们介绍一例心脏再同步治疗植入后合并心包积液的明信片损伤综合征,仅使用秋水仙碱治疗。尽管使用秋水仙碱的治疗并不像非甾体抗炎药或类固醇那么普遍,但是秋水仙碱似乎是该综合征的一种有效且安全的治疗选择。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号